-
Loading metrics
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer
- Ravi K. Anchoori,
- Ssu-Hsueh Tseng,
- Hua-Ling Tsai,
- Vikrant Palande,
- Michelle A. Rudek,
- Richard B. S. Roden
x
- Published: July 11, 2024
- https://doi.org/10.1371/journal.pone.0305710